BENCHMARK ELECTRONICS INC Q3 FY2026 earnings call

• Record Financials: Revenue reached $811 million and EPS hit 84 cents, both exceeding the high end of guidance. Non-GAAP operating margin improved 70 basis points year-over-year to 5.5%, demonstrating significant leverage as earnings grew nearly twice the rate of sales.
• Sector Momentum: Demand is accelerating across most markets. Semi-Cap benefits from industry-wide capacity investments with visibility extending into 2029/2030. Industrial has turned the corner after prior flat expectations. Medical continues double-digit growth trajectory with new large-program wins. A&D bookings are at record levels, positioning for growth in 2027 despite a 2026 pause.
• Operational Execution: The company successfully expanded manufacturing footprint for a key AI infrastructure customer on a compressed timeline. PT4 in Penang came online in July 2026, supporting semiconductor growth. Planned facilities in Thailand are expected to complete in late 2027.
• Capital Discipline: Free cash flow generation remains strong ($14 million in Q3). The cash conversion cycle improved 23 days year-over-year to 54 days. The balance sheet is strengthened with $291 million in cash and $576 million in total borrowing capacity.

Benchmark Electronics reported record revenue of $811 million, a 19% year-over-year increase. The Semiconductor Capital Equipment (Semi-Cap) segment led growth with a 30% year-over-year and 8% sequential increase, driven by strong market demand and new program wins. Industrial revenue grew 13% year-over-year and 7% sequentially, supported by new awards from existing customers. Medical sector revenue increased 9% year-over-year and 3% sequentially, primarily due to program ramps. Aerospace & Defense (A&D) saw a slight 1% year-over-year decline but achieved strong 15% sequential growth. AC&C (Automotive, Commercial & Consumer) delivered exceptional performance with 50% year-over-year growth and 4% sequential growth, aided by major ramp-ups.

• Q4 2026 Revenue: Guided to $815 million - $855 million, representing 19% year-over-year growth at the midpoint.
• Full Year 2026 Revenue: Raised outlook to exceed $3 billion, reflecting 16% annual growth.
• Full Year 2026 EPS: Non-GAAP diluted EPS projected between 85 and 91 cents.
• Margins: Non-GAAP gross margin expected at 10.5% - 10.7%; Non-GAAP operating margin at 5.5% - 5.7%.
• Tax Rate: Effective tax rate anticipated between 25% and 26% for Q4, showing progress in structurally lowering the rate.
• Capital Expenditures: Full-year capex expected to remain in the range of 2% to 2.5% of revenue.

• Supply Chain Constraints: Persistent supply chain issues, particularly regarding memory and ASIC components, require active management through selective inventory investments and joint planning with customers.
• Capacity Ramp Timing: While PT4 is online, future growth relies on the successful ramp of new facilities in Thailand (late 2027) and managing inventory levels during global production transitions.
• Market Volatility: Although durability is cited, specific sectors like A&D face timing-related pauses in growth for 2026, dependent on multi-year program cycles.

Q: Analyst asked about the sustainability of growth into 2027 beyond current forecasts. / A: CEO cited three pillars: customer visibility into 2027, ongoing ramps from bookings secured in 2025/2026, and proactive customer engagement. He emphasized that momentum is sustained by converting these bookings into production, with no reason to believe the trend will reverse.

Q: Analyst questioned if current capacity can handle acceleration and asked about remaining operational leverage. / A: CEO confirmed PT4’s July 2026 launch positions them well for semi-cap growth. CFO added that gross margins will benefit from filling PT4 capacity, while operating margins will improve next year due to reduced variable compensation headwinds and other efficiency initiatives, maintaining the target of earnings growing 1.5x-2x revenue.

Q: Analyst sought clarification on AC&C growth drivers and product types. / A: CEO explained that AC&C’s 50% growth is driven by on-premises AI products. The demand accelerated so rapidly that Benchmark had to expand its manufacturing footprint mid-ramp to meet customer needs, a move they executed successfully, with momentum continuing into 2027.

Q: Analyst asked about HVC opportunities previously mentioned as early 2027 and recent supply chain risks. / A: CEO clarified that High-Volume Connectivity (HVC) opportunities have shifted slightly later to mid-to-late 2027 due to customer timing but layer on top of existing work. Regarding supply chains, he acknowledged ASIC and memory challenges but noted they are mitigating this through strategic inventory investments and close collaboration with suppliers and customers.

Q: Analyst inquired about medical sector sustainability and cash flow priorities. / A: CEO stated medical demand is recovering strongly, with potential for growth beyond 2027 driven by new large-program wins that take time to ramp. CFO highlighted strong free cash flow ($113M trailing 12 months) and share buybacks, noting a long-range target of five inventory turns, accepting temporary slips due to active production ramps.